Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Anosmia and other SARS-CoV-2 positive test-associated symptoms, across three national, digital surveillance platforms as the COVID-19 pandemic and response unfolded: an observation study

View ORCID ProfileCarole H. Sudre, View ORCID ProfileAyya Keshet, View ORCID ProfileMark S. Graham, Amit D. Joshi, Smadar Shilo, View ORCID ProfileHagai Rossman, Benjamin Murray, View ORCID ProfileErika Molteni, View ORCID ProfileKerstin Klaser, View ORCID ProfileLiane D Canas, Michela Antonelli, View ORCID ProfileMarc Modat, View ORCID ProfileJoan Capdevila Pujol, View ORCID ProfileSajaysurya Ganesh, View ORCID ProfileJonathan Wolf, View ORCID ProfileTomer Meir, Andrew T. Chan, View ORCID ProfileClaire J. Steves, View ORCID ProfileTim D. Spector, View ORCID ProfileJohn S. Brownstein, View ORCID ProfileEran Segal, View ORCID ProfileSebastien Ourselin, View ORCID ProfileChristina M. Astley
doi: https://doi.org/10.1101/2020.12.15.20248096
Carole H. Sudre
1MRC Unit for Lifelong health and Ageing at UCL, Department of Population Science and Experimental Medicine, University College London, London, UK
2Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK
3School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carole H. Sudre
  • For correspondence: c.sudre{at}ucl.ac.uk
Ayya Keshet
4Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
5Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ayya Keshet
Mark S. Graham
3School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark S. Graham
Amit D. Joshi
6Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School. Boston, Massachusetts, USA
7Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School. Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Smadar Shilo
4Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
5Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
8Pediatric Diabetes Unit, Ruth Rappaport Children’s Hospital, Rambam Healthcare Campus, Haifa, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hagai Rossman
4Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
5Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hagai Rossman
Benjamin Murray
3School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erika Molteni
3School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erika Molteni
Kerstin Klaser
3School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kerstin Klaser
Liane D Canas
3School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Liane D Canas
Michela Antonelli
3School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Modat
3School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc Modat
Joan Capdevila Pujol
9Department of Twin Research and Genetic Epidemiology, King’s College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joan Capdevila Pujol
Sajaysurya Ganesh
9Department of Twin Research and Genetic Epidemiology, King’s College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sajaysurya Ganesh
Jonathan Wolf
9Department of Twin Research and Genetic Epidemiology, King’s College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan Wolf
Tomer Meir
4Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
5Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tomer Meir
Andrew T. Chan
6Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School. Boston, Massachusetts, USA
7Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School. Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire J. Steves
9Department of Twin Research and Genetic Epidemiology, King’s College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claire J. Steves
Tim D. Spector
9Department of Twin Research and Genetic Epidemiology, King’s College London, UK
10Zoe Global Limited
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tim D. Spector
John S. Brownstein
11Computational Epidemiology Lab, Boston Children’s Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John S. Brownstein
Eran Segal
4Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
5Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eran Segal
Sebastien Ourselin
3School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sebastien Ourselin
Christina M. Astley
11Computational Epidemiology Lab, Boston Children’s Hospital, Boston, MA, USA
12Division of Endocrinology, Boston Children’s Hospital, Boston, MA, USA
13Broad Institute of Harvard and MIT, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christina M. Astley
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Multiple participatory surveillance platforms were developed across the world in response to the COVID-19 pandemic, providing a real-time understanding of community-wide COVID-19 epidemiology. During this time, testing criteria broadened and healthcare policies matured. We sought to test whether there were consistent associations of symptoms with SARS-CoV-2 test status across three national surveillance platforms, during periods of testing and policy changes, and whether inconsistencies could better inform our understanding and future studies as the COVID-19 pandemic progresses.

Methods Four months (1st April 2020 to 31st July 2020) of observation through three volunteer COVID-19 digital surveillance platforms targeting communities in three countries (Israel, United Kingdom, and United States). Logistic regression of self-reported symptom on self-reported SARS-CoV-2 test status (or test access), adjusted for age and sex, in each of the study cohorts. Odds ratios over time were compared to known changes in testing policies and fluctuations in COVID-19 incidence.

Findings Anosmia/ageusia was the strongest, most consistent symptom associated with a positive COVID-19 test, based on 658,325 tests (5% positive) from over 10 million respondents in three digital surveillance platforms using longitudinal and cross-sectional survey methodologies. During higher-incidence periods with broader testing criteria, core COVID-19 symptoms were more strongly associated with test status. Lower incidence periods had, overall, larger confidence intervals.

Interpretation The strong association of anosmia/ageusia with self-reported SARS-CoV-2 test positivity is omnipresent, supporting its validity as a reliable COVID-19 signal, regardless of the participatory surveillance platform or testing policy. This analysis highlights that precise effect estimates, as well as an understanding of test access patterns to interpret differences, are best done only when incidence is high. These findings strongly support the need for testing access to be as open as possible both for real-time epidemiologic investigation and public health utility.

Funding NIH, NIHR, Alzheimer’s Society, Wellcome Trust

Evidence before this study As the COVID-19 pandemic has evolved, testing capacity expanded and governmental guidelines adapted, generally encouraging testing with a broader set of symptoms, not just fever with respiratory symptoms. In parallel, multiple large-scale citizen science digital surveillance platforms launched to complement knowledge from laboratory and somewhat smaller clinical studies. Symptoms such as loss of sense of smell have been identified as strongly predictive of COVID-19 infection in both clinical and syndromic surveillance analyses, and have therefore been used to inform these testing policy changes and access expansion.

Added value of this study This study identifies symptoms that are or are not consistently associated with SARS-CoV-2 test positivity over time and across three country-based COVID-19 surveillance platforms in the United States, United Kingdom and Israel. These platforms are website and smartphone based, as well as cross-sectional and longitudinal. The study period of 4 months covers fluctuating COVID-19 prevalence during the fall of the first wave and, in some areas, rise of the second wave. In addition, the study period overlaps expansion of test access and test seeking. Importantly, these analyses track and highlight the value of individual symptoms to predict SARS-CoV-2 test positivity under a range of conditions.

Implications of all the available evidence Despite differences in surveillance methodology, access to SARS-CoV-2 testing and disease prevalence, loss of sense of smell or taste was consistently the strongest predictor of COVID-19 infection across all platforms over time. As access to testing broadened, the relevance of COVID-like symptoms and consistency of their predictive ability became apparent. However, confidence bounds generally widened with a fall in COVID-19 incidence. Therefore, for the most robust symptom-based COVID-19 prediction models should consider surveillance data during periods of higher incidence and improved test access, and effect estimates that replicate across different epidemiologic conditions and platforms.

Competing Interest Statement

Zoe Global Limited co-developed the app pro bono for non-commercial purposes. Investigators received support from the Wellcome Trust, the MRC/BHF, EU, NIHR, CDRF, and the NIHR-funded BioResource, Clinical Research Facility and BRC based at GSTT NHS Foundation Trust in partnership with KCL. JW, JCP, SG work for Zoe Global Limited and TDS and is consultant to Zoe Global Limited. ATC previously participated as investigator on a diet study unrelated to this work that was supported by Zoe Global Ltd.

Funding Statement

Zoe provided in kind support for all aspects of building, running and supporting the app and service to all users worldwide. Support for this study was provided by the NIHR-funded Biomedical Research Centre based at GSTT NHS Foundation Trust. This work was supported by the UK Research and Innovation London Medical Imaging & Artificial Intelligence Centre for Value Based Healthcare. Investigators also received support from the Wellcome Trust, the MRC/BHF, Alzheimer's Society, EU, NIHR, CDRF, and the NIHR-funded BioResource, Clinical Research Facility and BRC based at GSTT NHS Foundation Trust in partnership with KCL. ATC was supported in this work through a Stuart and Suzanne Steele MGH Research Scholar Award.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Research studies on data collected through the app are approved by King's College London Ethics Committee REMAS ID 18210, review reference LRS-19/20-18210 and all participants provided consent. This study was approved by the Boston Children's Hospital IRB (P00023700​). This study was approved by the Weizmann Institute of Science review board (IRB). The IRB waived informed consent as all identifying information was removed prior to analysis.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Israel Platform Tables of de-identified, aggregated data are available at https://github.com/hrossman/Covid19-Survey. UK Platform Data used in this study is available to bona fide researchers through UK Health Data Research using the following link https://web.www.healthdatagateway.org/dataset/fddcb382-3051-4394-8436-b92295f14259 US Platform: Requests for access to the US Carnegie Mellon University/ Facebook COVID-19 Symptom Survey available via https://dataforgood.fb.com/docs/covid-19-symptom-survey-request-for-data-access/.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted December 16, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Anosmia and other SARS-CoV-2 positive test-associated symptoms, across three national, digital surveillance platforms as the COVID-19 pandemic and response unfolded: an observation study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Anosmia and other SARS-CoV-2 positive test-associated symptoms, across three national, digital surveillance platforms as the COVID-19 pandemic and response unfolded: an observation study
Carole H. Sudre, Ayya Keshet, Mark S. Graham, Amit D. Joshi, Smadar Shilo, Hagai Rossman, Benjamin Murray, Erika Molteni, Kerstin Klaser, Liane D Canas, Michela Antonelli, Marc Modat, Joan Capdevila Pujol, Sajaysurya Ganesh, Jonathan Wolf, Tomer Meir, Andrew T. Chan, Claire J. Steves, Tim D. Spector, John S. Brownstein, Eran Segal, Sebastien Ourselin, Christina M. Astley
medRxiv 2020.12.15.20248096; doi: https://doi.org/10.1101/2020.12.15.20248096
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Anosmia and other SARS-CoV-2 positive test-associated symptoms, across three national, digital surveillance platforms as the COVID-19 pandemic and response unfolded: an observation study
Carole H. Sudre, Ayya Keshet, Mark S. Graham, Amit D. Joshi, Smadar Shilo, Hagai Rossman, Benjamin Murray, Erika Molteni, Kerstin Klaser, Liane D Canas, Michela Antonelli, Marc Modat, Joan Capdevila Pujol, Sajaysurya Ganesh, Jonathan Wolf, Tomer Meir, Andrew T. Chan, Claire J. Steves, Tim D. Spector, John S. Brownstein, Eran Segal, Sebastien Ourselin, Christina M. Astley
medRxiv 2020.12.15.20248096; doi: https://doi.org/10.1101/2020.12.15.20248096

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13403)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5182)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4225)
  • Public and Global Health (7526)
  • Radiology and Imaging (1717)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (73)
  • Transplantation (237)
  • Urology (206)